Cytomegalovirus (CMV) Infection Treatment and Diagnosis Market Dynamic Revenue 2020, Business Forecast, Global Analysis by Size, Key Trends, Comprehensive Analysis by Top Leader And Industry Forecast by 2026

Cytomegalovirus (CMV) is a type of herpes virus that remains dormant in the human body and can cause complications during pregnancy and people with weak immune system. This virus can spread through body fluids and can pass from pregnant mother to her unborn baby. Some of the symptoms of CMV are fever, night sweats, uneasiness and tiredness, weight loss, swollen glands, joint and muscle pain, sore throat, and low appetite. Eyes, lungs, or the digestive system is the area likely to be most affected. Presence of CMV infection can be detected by various testing methods based on which the global cytomegalovirus infection treatment and diagnosis market can be analyzed by using Serologic test and Polymerase chain reaction (PCR) test.

Get PDF Research Brochure for more Professional and Technical Insights: https://www.coherentmarketinsights.com/insight/request-sample/167

CMV diagnosis is very important in pregnant women and immunocompromised individuals. Enzyme-linked immunoassay test is the most widely used serologic testing for CMV infection in laboratories. Besides, the PCR technique is also implemented for testing samples of saliva, and urine.

Cytomegalovirus infection market: a Treatment approach

Anti-viral medications are basically given to the patient to prevent the disease to get into the active stage. However, there is no cure available for treating the CMV infection. Some of the common anti-viral medications available in the market are Ganciclovir, Val ganciclovir, Cidofovir, Valacyclovir, and Foscarnet are few major anti-viral medications prescribed. In some cases, CMV immune globulin contains antibodies (proteins) that may be prescribed to prevent CMV infection. Moreover, there are certain products in the pipeline which include Cytovir CMV, Letermovir, CytoTect CP 70, Brincidofovir and ASP0113, commercialization of which is expected to fuel the global CMV infection treatment and diagnosis market growth in the upcoming years.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/167

Vital statistics for the global cytomegalovirus infection treatment and diagnosis market

Increasing the diagnosis of CMV infection is likely to propel the market growth of cytomegalovirus.  The Public Health Agency of Canada estimates that 40%-100% of the global population have CMV antibody present in their bodies. Immunocompromised patients (HIV, organ transplant), premature infants, newborns, and congenital CMV are at high risk of developing a CMV infection.

According to the Centers for Disease Control and Prevention (CDC), one in every 150 infants are born with congenital cytomegalovirus (CMV) infection in the U.S. However, only one in five infants infected with CMV has long term health problems. Increasing infection rates and demand for effective treatment therapies will further propel the cytomegalovirus infection treatment and diagnosis of market growth.

Regional Overview

Early diagnosis practices would fuel the global cytomegalovirus infection treatment and diagnosis market across developed regions such as North America and Europe, as these areas have easy accessibility to advanced diagnostic and treatment facilities as compared to the emerging economies. For market players in the diagnosis and treatment of CMV infection, ensuring accessibility and healthcare investment in emerging nations would be critical to generate a better returns on investments.

Some of the major players in the global cytomegalovirus infection treatment and diagnosis market are Merck & Co. Inc., Cell Medical Ltd., Chimerix, Inc., Affymetrix, Inc., Abbott Laboratories, Inc., Becton, Dickinson and Company, Johnson & Johnson, Bio-Rad Laboratories, Inc., and F. Hoffmann-La Roche Ltd.

To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/cytomegalovirus-infection-treatment-and-diagnosis-market-167

Key Developments

• Major institutes are focused on launching various programs focused on R&D activities related to cytomegalovirus (CMV) infection. For instance, in August 2019, The UW Program for Advanced Cell Therapy (PACT) launched first-in-US cell-therapy trial for kidney transplant patients that will deploy virus-specific white blood cells for the treatment of severe cytomegalovirus (CMV) infection after kidney transplantation.
• Moreover, in January 2019, a team of researchers from Lions Eye Institute (LEI), a medical research institute affiliated with the University of Western Australia, discovered a new method to prevent reactivation of CMV in mouse models by injecting them with their own antibodies. The research is expected to offer a new strategy to control CMV reactivation in humans.
• In November 2018, a study by University Children’s Hospital Tuebingen, Germany — published in the journal Clinical Infectious Diseases of Infectious Diseases Society of America— found that short-term pasteurization of breast milk prevents postnatal CMV transmission in very preterm infants.

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837